Field performance and cost‐effectiveness of a point‐of‐care triage test for HIV virological failure in Southern Africa

Field performance and cost‐effectiveness of a point‐of‐care triage test for HIV virological failure in Southern Africa

Abstract Introduction Antiretroviral therapy (ART) monitoring using viral load (VL) testing is challenging in high‐burden, limited‐resources settings. Chemokine IP‐10 (interferon gamma‐induced protein 10) strongly correlates with human immunodeficiency virus (HIV) VL. Its determination could serve t...

Full description

Bibliographic Details
Main Authors:	Anna Saura‐Lázaro, Peter Bock, Erika van den Bogaart, Jessie vanVliet, Laura Granés, Kerry Nel, Vikesh Naidoo, Michelle Scheepers, Yvonne Saunders, Núria Leal, Francesco Ramponi, René Paulussen, Tobias Rinke deWit, Denise Naniche, Elisa López‐Varela
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Journal of the International AIDS Society
Subjects:	cost‐effectiveness analysis CXC chemokine IP‐10 human immunodeficiency virus point‐of‐care test Southern Africa therapeutic drug monitoring
Online Access:	https://doi.org/10.1002/jia2.26176

Similar Items

Evolutionarily conserved mechanisms regulating stress-induced neutrophil redistribution in fish
by: Katarzyna Klak, et al.
Published: (2024-03-01)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
by: Xinxin Huang, et al.
Published: (2022-02-01)

CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
by: Caitlin Molczyk, et al.
Published: (2023-02-01)

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
by: Xiaoqi Sun, et al.
Published: (2021-07-01)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
by: Alireza Nazari, et al.
Published: (2020-03-01)

The Role of CXC Chemokines in Cancer Progression
by: Tiantian Wu, et al.
Published: (2022-12-01)

CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis
by: Lu Wang, et al.
Published: (2020-02-01)

CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions
by: Mohammad Hassan Mohammadi, et al.
Published: (2021-06-01)

ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
by: Boshagh MA, et al.
Published: (2019-06-01)

The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses
by: Mojgan Noroozi Karimabad, et al.
Published: (2022-08-01)

Sequence characterization and expression pattern analysis of chemokines CXCL13 and CXCL14 in Asian swamp eel
by: Dingda Xu, et al.
Published: (2020-11-01)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
by: Joanna Motyka, et al.
Published: (2023-06-01)

Targeting G protein-coupled receptor for pain management
by: Hongyan Li, et al.
Published: (2017-01-01)

Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
by: Lian-Tao Hu, et al.
Published: (2022-06-01)

PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2005-03-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

Correlation between the expressions of CXCL8 and miR-150 in the skin lesions and the severity of psoriasis vulgaris
by: MA Hui, BI Xiaodong
Published: (2023-02-01)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
by: Jan Korbecki, et al.
Published: (2021-01-01)

The CXC Chemokine Receptors in Four-Eyed Sleeper (<i>Bostrychus sinensis</i>) and Their Involvement in Responding to Skin Injury
by: Mengdan Dong, et al.
Published: (2021-09-01)

Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression
by: Min Jae H, et al.
Published: (2012-07-01)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
by: Yanhua Jing, et al.
Published: (2022-04-01)

CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1
by: Zhao D, et al.
Published: (2019-12-01)

Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice
by: Michael Guo, et al.
Published: (2018-04-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway
by: Jia-Hui Gao, et al.
Published: (2019-12-01)

Silenced CXCL12 inhibits ox-LDL-induced foaming and apoptosis in mouse macrophage cell line RAW264.7
by: ZHUANG Hong, ZHANG Su-chuan, LIU Hui-di, XU Ya-ning, HUANG Lu, DAI Tian, JIANG Pin
Published: (2021-02-01)

Molecular Identification and Dual Functions of Two Different CXC Chemokines in Nile Tilapia (<i>Oreochromis niloticus</i>) against <i>Streptococcus agalactiae</i> and <i>Flavobacterium columnare</i>
by: Chatsirin Nakharuthai, et al.
Published: (2020-07-01)

Association of Gene Polymorphisms in CXC Chemokine Receptor 5 with Rheumatoid Arthritis Susceptibility
by: Zhenzhen Su, et al.
Published: (2022-10-01)

Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway
by: Cheng Ju, et al.
Published: (2023-02-01)

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
by: Prajwal Boddu, et al.
Published: (2018-09-01)

Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis
by: Caiyun Wu, et al.
Published: (2021-09-01)

Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation
by: Sung-Tai Wei, et al.
Published: (2021-05-01)

Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
by: Yixiang Cao, et al.
Published: (2022-05-01)

Circulating CXCR5+ natural killer cells are expanded in patients with myasthenia gravis
by: Meng‐Ru Ge, et al.
Published: (2023-01-01)

A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01)

The Role of CXC Chemokines in Cardiovascular Diseases
by: Xiyi Lu, et al.
Published: (2022-05-01)

Salicylic Acid and NIM1/NPR1-Independent Gene Induction by Incompatible Peronospora parasitica in Arabidopsis
by: Gregory J. Rairdan, et al.
Published: (2001-10-01)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
by: Weina Kong, et al.
Published: (2021-07-01)

A focus on CXCR4 in Alzheimer's disease
by: Hongyan Li, et al.
Published: (2017-01-01)

The Impact of Different Types of Physical Effort on the Expression of Selected Chemokine and Interleukin Receptor Genes in Peripheral Blood Cells
by: Robert Nowak, et al.
Published: (2023-04-01)